Recommendation
- https://pmc.ncbi.nlm.nih.gov/articles/PMC10078904/Resection of NAFLD/NASH-related Hepatocellular Carcinoma (HCC ...Resection of NAFLD/NASH-related Hepatocellular Carcinoma (HCC): Clinical Features and Outcomes Compared with HCC Due to Other Etiologies
- https://pubmed.ncbi.nlm.nih.gov/36763374/PubMedResection of NAFLD/NASH-related Hepatocellular Carcinoma (HCC ...Apr 6, 2023 ... Patients with NAFLD/NASH-related HCC more commonly lacked liver fibrosis and presented with larger HCCs compared with patients with HCC from ...
- https://www.nature.com/articles/s41575-019-0145-7From NASH to HCC: current concepts and future challenges | Nature ...Apr 26, 2019 ... Of these, NASH is unique as it includes chronic hepatitis, necroinflammation and a complex metabolic disease. NAFLD is characterized by hepatic ...
- https://www.sciencedirect.com/science/article/pii/S2589555921000811Epidemiology of non-alcoholic fatty liver disease and hepatocellular ...The presence of type 2 diabetes increases the risk of HCC 2-fold and risk of death from HCC 1.5-fold. •. The presence of metabolic syndrome along with type 2 ...
- https://www.nature.com/articles/s41586-021-03362-0NASH limits anti-tumour surveillance in immunotherapy-treated HCCMar 24, 2021 ... Approximately 10–20% of individuals with NAFLD progress over time from steatosis to NASH. Innate and adaptive immune-cell activation, in ...
- https://www.mdpi.com/1422-0067/22/9/4495Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity ...The etiology of NAFLD/NASH-derived HCC is very complex and is related with various mechanisms such as cellular plasticity, inflammation, apoptosis, cell cycle, ...
- https://www.e-jlc.org/journal/view.php?number=514Non-alcoholic fatty liver disease-related hepatocellular carcinomaNAFLD currently accounts for approximately 20% of HCC, although this is anticipated to increase in most countries over the next decade. Herein, we ...
- https://www.bcm.edu/sites/default/files/risk-of-hcc-in-nash.pdfRisk of HCC in NAFLD/NASHPage 1. Risk of HCC in NAFLD/NASH. Fasiha Kanwal, MD, MSHS. Professor of Medicine. Baylor College of Medicine. Houston, Texas. Page 2. • Simple fatty liver is.
- https://insight.jci.org/articles/view/168476miR-33 deletion in hepatocytes attenuates MASLD-MASH-HCC ...Aug 27, 2024 ... Metabolic aspects in NAFLD, NASH and hepatocellular carcinoma: the role of PGC1 coactivators. Nat Rev Gastroenterol Hepatol. 2019;16(3):160 ...
- https://gut.bmj.com/content/71/10/2093CXCR2 inhibition enables NASH-HCC immunotherapy | Gut... fatty liver disease (NAFLD)-HCC and NASH-HCC patient resected tissue. (J) Heatmap showing row-scaled expression of neutrophil-associated process networks ...
Recommend
All Categories
Others
Privacy Policy
Terms of Use
We scour the internet for answers to just about everything - from finding the latest kitchenware to finding
the best travel destinations.
A unique Q&A structure provides you with relevant information in a quick-read, easy-to-use format. With the
most common questions answered in this format, you're sure to find what you're looking for.
Copyright © 2024 Seahia. All rights reserved